Treatment response and drug retention rates in 24 195 biologic-naive patients with axial spondyloarthritis initiating TNFi treatment: routine care data from 12 registries in the EuroSpA collaboration


Ornbjerg L. M., Brahe C. H., Askling J., Ciurea A., Mann H., ÖNEN F., ...Daha Fazla

ANNALS OF THE RHEUMATIC DISEASES, cilt.78, sa.11, ss.1536-1544, 2019 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 78 Sayı: 11
  • Basım Tarihi: 2019
  • Doi Numarası: 10.1136/annrheumdis-2019-215427
  • Dergi Adı: ANNALS OF THE RHEUMATIC DISEASES
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.1536-1544
  • Dokuz Eylül Üniversitesi Adresli: Evet

Özet

Objective To study drug retention and response rates in patients with axial spondyloarthritis (axSpA) initiating a first tumour necrosis factor inhibitor (TNFi).